Sun Pharma, Dr Reddy’s, and Aurobindo Pharma Recall Products in the US
Drug manufacturers Sun Pharma, Dr Reddy’s, and Aurobindo Pharma are recalling their products in the United States of America market due to manufacturing issues, according to...
Tag : Dr Reddy’s Laboratories
Dr Reddy’s Lab Reportedly Plans to Acquire Novartis India, Both Shares Hit 52-week High
Shares of Novartis India and Dr Reddy’s Laboratories hit fresh 52-week highs after reports surfaced suggesting that Dr Reddy’s plans to acquire Switzerland-based pharma company...
Dr Reddy’s Shares Hit 52-Week High on Receiving VAI Status from USFDA
Shares of Dr Reddy’s Laboratories Ltd hit a 52-week high of Rs 6,388.45 on 12 February after USFDA (US Food and Drug Administration) cleared its...
Dr Reddy’s Laboratories Plunged 7% as USFDA Issued Observations for Telangana Unit
Shares of Dr Reddy’s Laboratories Plummeted 7% on 11 December after the USFDA (US Food and Drug Administration) issued three observations for its unit in...
Dr Reddy’s Laboratories Shares Gain 2% as Arm Partners with COYA for ALS Drug
Dr Reddy’s Laboratories shares were trading in the green and 2% higher on 7 December after the company announced that its wholly-owned subsidiary, Dr Reddy’s...
Dr Reddy’s Quarterly Report for Q2; Net Profit at Rs 1,480 Crore
Dr Reddy’s Laboratories on October 27 announced its quarterly report for the July-September quarter. The company reported its highest-ever consolidated net profit at Rs 1,480...
Dr Reddy’s Laboratory Shares Reach 52-Week High, PAI at Srikakulam Unit Concludes With Zero Observation
Shares of Dr Reddy’s Laboratory rose 2% in early trade of July 20 to reach a new 52-week high of Rs 5,360 after the US...
Dr Reddy’s Shares Rise as Drugmaker Demerges 9 Dermal Brands in Rs 275 Crore
Shares of Dr Reddy’s Laboratories climbed on March 17 after the company said it had signed a deal to sell nine of its non-core brands...
Dr. Reddy’s Labs Gains to 1.99%
Dr. Reddy’s Laboratories consolidated net profit rose 1.99 per cent to Rs 4549.80 after the company reported a 12 per cent growth in net profit...
Back-to-Back USFDA Approvals Boost Zydus Lifesciences, Shares Hit 8-Month High
Zydus Lifesciences’ drug hit an eight-month high following a string of US regulatory approvals. The stock hit Rs 426 on the NSE on October 7...